Literature DB >> 12784292

Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease.

L Djoussé1, B Knowlton, M Hayden, E W Almqvist, R Brinkman, C Ross, R Margolis, A Rosenblatt, A Durr, C Dode, P J Morrison, A Novelletto, M Frontali, R J A Trent, E McCusker, E Gómez-Tortosa, D Mayo, R Jones, A Zanko, M Nance, R Abramson, O Suchowersky, J Paulsen, M Harrison, Q Yang, L A Cupples, J F Gusella, M E MacDonald, R H Myers.   

Abstract

Huntington disease (HD) is a neurodegenerative disorder caused by the abnormal expansion of CAG repeats in the HD gene on chromosome 4p16.3. Past studies have shown that the size of expanded CAG repeat is inversely associated with age at onset (AO) of HD. It is not known whether the normal Huntington allele size influences the relation between the expanded repeat and AO of HD. Data collected from two independent cohorts were used to test the hypothesis that the unexpanded CAG repeat interacts with the expanded CAG repeat to influence AO of HD. In the New England Huntington Disease Center Without Walls (NEHD) cohort of 221 HD affected persons and in the HD-MAPS cohort of 533 HD affected persons, we found evidence supporting an interaction between the expanded and unexpanded CAG repeat sizes which influences AO of HD (P = 0.08 and 0.07, respectively). The association was statistically significant when both cohorts were combined (P = 0.012). The estimated heritability of the AO residual was 0.56 after adjustment for normal and expanded repeats and their interaction. An analysis of tertiles of repeats sizes revealed that the effect of the normal allele is seen among persons with large HD repeat sizes (47-83). These findings suggest that an increase in the size of the normal repeat may mitigate the expression of the disease among HD affected persons with large expanded CAG repeats. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12784292     DOI: 10.1002/ajmg.a.20190

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  66 in total

1.  A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.

Authors:  Damian M Cummings; Yasaman Alaghband; Miriam A Hickey; Prasad R Joshi; S Candice Hong; Chunni Zhu; Timothy K Ando; Véronique M André; Carlos Cepeda; Joseph B Watson; Michael S Levine
Journal:  J Neurophysiol       Date:  2011-11-09       Impact factor: 2.714

2.  Genetic background modulates behavioral impairments in R6/2 mice and suggests a role for dominant genetic modifiers in Huntington’s disease pathogenesis.

Authors:  Randi-Michelle Cowin; Nghiem Bui; Deanna Graham; Jennie R Green; Lisa A Yuva-Paylor; Andreas Weiss; Richard Paylor
Journal:  Mamm Genome       Date:  2012-06       Impact factor: 2.957

Review 3.  Huntington's disease genetics.

Authors:  Richard H Myers
Journal:  NeuroRx       Date:  2004-04

4.  Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.

Authors:  J M Andresen; J Gayán; S S Cherny; D Brocklebank; G Alkorta-Aranburu; E A Addis; L R Cardon; D E Housman; N S Wexler
Journal:  J Med Genet       Date:  2006-10-03       Impact factor: 6.318

Review 5.  CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.

Authors:  Douglas R Langbehn; Michael R Hayden; Jane S Paulsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

6.  Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains.

Authors:  Guang Bai; Iris Cheung; Hennady P Shulha; Joana E Coelho; Ping Li; Xianjun Dong; Mira Jakovcevski; Yumei Wang; Anastasia Grigorenko; Yan Jiang; Andrew Hoss; Krupal Patel; Ming Zheng; Evgeny Rogaev; Richard H Myers; Zhiping Weng; Schahram Akbarian; Jiang-Fan Chen
Journal:  Hum Mol Genet       Date:  2014-12-05       Impact factor: 6.150

7.  Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype.

Authors:  Nicola J Rutherford; Michael G Heckman; Mariely Dejesus-Hernandez; Matt C Baker; Alexandra I Soto-Ortolaza; Sruti Rayaprolu; Heather Stewart; Elizabeth Finger; Kathryn Volkening; William W Seeley; Kimmo J Hatanpaa; Catherine Lomen-Hoerth; Andrew Kertesz; Eileen H Bigio; Carol Lippa; David S Knopman; Hans A Kretzschmar; Manuela Neumann; Richard J Caselli; Charles L White; Ian R Mackenzie; Ronald C Petersen; Michael J Strong; Bruce L Miller; Bradley F Boeve; Ryan J Uitti; Kevin B Boylan; Zbigniew K Wszolek; Neill R Graff-Radford; Dennis W Dickson; Owen A Ross; Rosa Rademakers
Journal:  Neurobiol Aging       Date:  2012-07-26       Impact factor: 4.673

8.  Drosophila Models of Huntington's Disease exhibit sleep abnormalities.

Authors:  Erin Gonzales; Jerry Yin
Journal:  PLoS Curr       Date:  2010-09-29

9.  DNA instability in replicating Huntington's disease lymphoblasts.

Authors:  Milena Cannella; Vittorio Maglione; Tiziana Martino; Giuseppe Ragona; Luigi Frati; Guo-Min Li; Ferdinando Squitieri
Journal:  BMC Med Genet       Date:  2009-02-11       Impact factor: 2.103

10.  Huntington's disease: the case for genetic modifiers.

Authors:  James F Gusella; Marcy E MacDonald
Journal:  Genome Med       Date:  2009-08-21       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.